Role of B Cells in Breaking and Maintaining Tolerance to Clotting Factor VIII in Congenital and Acquired Hemophilia A

Immune responses directed against clotting factor FVIII (FVIII) seriously complicate treatments for patients with hemophilia A. This response can manifest in congenital hemophilia A patients who generate inhibitor antibodies that bind and inactivate “transplanted” replacement FVIII, as well as in ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Amanda M. Actor, Claire K. Holley, Keri Csencsits-Smith
Formato: Artículo
Lenguaje:English
Publicado: MDPI AG 2014-04-01
Colección:Antibodies
Materias:
Acceso en línea:http://www.mdpi.com/2073-4468/3/2/192